Drugs / CD8+T cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03093688 | Mar 2017 → Dec 2030 expected | gastric cancer, hepatocellular carcinoma, malignant pancreatic neoplasm, non-small cell lung carcinoma +2 | Shanghai Public Health Clinical Center | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD8+T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03093688 ↗ |